GE HealthCare Technologies Inc. Cash & Equivalents 2020-2026 | GEHC
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is GE HealthCare Technologies Inc.'s current cash & equivalents?
GE HealthCare Technologies Inc. (GEHC) annual cash & equivalents for 2025 was $4.49B, a 55.27% increase from 2024. GE HealthCare Technologies Inc. cash & equivalents for the quarter ending March 31, 2026 was $2.26B.
What was GE HealthCare Technologies Inc.'s cash & equivalents in 2024?
GE HealthCare Technologies Inc. annual cash & equivalents for 2024 was $2.89B, a 15.44% increase from 2023.
What was GE HealthCare Technologies Inc.'s cash & equivalents in 2023?
GE HealthCare Technologies Inc. annual cash & equivalents for 2023 was $2.51B, a 72.71% increase from 2022.
What is GE HealthCare Technologies Inc.'s 5-year cash & equivalents CAGR?
GE HealthCare Technologies Inc. cash & equivalents grew at a compound annual growth rate (CAGR) of 34.73% from FY2020 to FY2025, going from $1.01B to $4.49B over 5 years.
Year-over-year comparison from 10-K annual reports